Additionally, a study by Da Costa et al. proposed treatment with the BET bromodomain inhibitor JQ1, an inhibitor of MYC transcription, as a way to sensitize ALL cells to dexamethasone treatment36. This evidence concerns the gene DNER and acute lymphoblastic leukemia.